Inventor
CONNOR DAVID THOMAS
US22 patents
⚠️ This page may combine multiple inventors who share the name “CONNOR DAVID THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WARNER LAMBERT CO
17 patentsUS6528528B2Mar 4, 2003
Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
WARNER LAMBERT CO22 citations91
US6268387B1Jul 31, 2001
Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
WARNER LAMBERT CO41 citations91
US6184235B1Feb 6, 2001
2-phenyl benzimidazole derivatives as MCP-1 antagonists
WARNER LAMBERT CO40 citations91
US6162830ADec 19, 2000
Benzenesulfonamide inhibitors of PDE-IV and their therapeutic use
WARNER LAMBERT CO69 citations91
US6051605AApr 18, 2000
Method of treating psychosis and schizophrenia
WARNER LAMBERT CO29 citations91
US6423689B1Jul 23, 2002
Peptidyl calcium channel blockers
WARNER LAMBERT CO48 citations90
US7015237B2Mar 21, 2006
Pyridine matrix metalloproteinase inhibitors
WARNER LAMBERT CO6 citations73
US5916914AJun 29, 1999
Compounds and method of treating psychosis and schizophrenia
WARNER LAMBERT CO7 citations71
US5703119ADec 30, 1997
Benzylidene-lactone derivatives of fenamates and their thiocarbonyl analogs as inhibitors of proteoglycan degradation
WARNER LAMBERT CO5 citations70
US6211209B1Apr 3, 2001
Method of inhibiting connective tissue degradation
WARNER LAMBERT CO14 citations69
US5703069ADec 30, 1997
Method for inhibiting and controlling viral growth
WARNER LAMBERT CO10 citations66
US6858739B2Feb 22, 2005
Indole and benzimidazole 15-lipoxygenase inhibitors
WARNER LAMBERT CO4 citations61
US5760050AJun 2, 1998
Antipsychotic method utilizing certain tetrahydrochromeno 3,4-c!pyridin-5-ones
WARNER LAMBERT CO3 citations60
US6995151B2Feb 7, 2006
Isophthalic acid derivatives as matrix metalloproteinase inhibitors
WARNER LAMBERT CO2 citations57
US6881743B2Apr 19, 2005
Pyridine matrix metalloproteinase inhibitors
WARNER LAMBERT CO1 citations51
US6020364AFeb 1, 2000
Compounds and method of treating psychosis and schizophrenia
WARNER LAMBERT CO1 citations49
US7214712B2May 8, 2007
Isophthalic acid derivatives as matrix metalloproteinase inhibitors
WARNER LAMBERT CO0 citations47
MILLENNIUM PHARM INC
4 patentsUS6548499B1Apr 15, 2003
Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
MILLENNIUM PHARM INC24 citations91
US6348487B1Feb 19, 2002
2-phenyl benzimidazole derivatives as MCP-1 antagonists
MILLENNIUM PHARM INC19 citations91
US6534521B2Mar 18, 2003
2-phenyl benzimidazole derivatives as MCP-1 antagonists
MILLENNIUM PHARM INC7 citations72
US6458806B1Oct 1, 2002
Aryl alkenamides derivatives as MCP-1 antagonists
MILLENNIUM PHARM INC2 citations59